Kenvue Inc
NYSE:KVUE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kenvue Inc
NYSE:KVUE
|
US |
|
I
|
Ilika PLC
OTC:ILIKF
|
UK |
|
Ping An Insurance (Group) Co of China Ltd
SSE:601318
|
CN |
|
N
|
Neofect Co Ltd
KOSDAQ:290660
|
KR |
Intrinsic Value
Is KVUE undervalued or overvalued?
See the intrinsic value estimate for Kenvue Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
KVUE looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with KVUE’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Kenvue Does
Kenvue is a consumer health company that sells everyday self-care products people buy without a prescription. Its brands include skin care, pain relief, cold and flu remedies, oral care, baby care, and wound care products. It makes money mainly by selling these branded products through pharmacies, grocery stores, mass retailers, club stores, and online channels.
- Headquarters
- United States of America US
- Employees
- 21 780
- IPO date
- May 4, 2023
Kenvue has a wide economic moat
Consumers’ willingness to pay more for trusted health brands helps Kenvue keep customers even when cheaper alternatives are available. Trust built around names such as Tylenol, supported by scientific research and healthcare professionals’ recommendations, is difficult for a new rival to reproduce quickly.
Read the full moat analysis
Earnings Waterfall
Kenvue Inc
The intrinsic value for Kenvue Inc (KVUE) under the Base Case is hidden USD.
Compared with the current market price of 19.56 USD, the stock appears hidden.